JOURNAL of
ONCOLOGICAL
SCIENCES

ORIGINAL RESEARCH ARTICLE

The Use of Patient-Reported Outcome Measures in Oncology: Perspectives of Oncologists
Received Date : 14 Feb 2024
Accepted Date : 18 Sep 2024
Available Online : 22 Oct 2024
Doi: 10.37047/jos.2024-102193 - Article's Language: EN
Journal of Oncological Sciences. 2024;10(3):125-31
This is an open access article under the CC BY-NC-ND license
ABSTRACT
Objective: This survey study was designed with the aim of assessing the use and opinions about patient-reported outcome measures (PROM) by healthcare workers in oncology clinics in Türkiye. Material and Methods: A 10-question survey was distributed to medical and radiation oncologists through digital platforms, receiving 334 complete responses. Results: Of the participants, 87.4% worked in medical oncology and 12.6% in radiation oncology clinics, respectively. 56% of participants reported less than 5 years of experience. Among participants, 11.7% of medical oncologists and 25% of radiation oncologists reported using PROMs in daily practice (p<0.05). In oncology clinics, it was revealed that PROMs were mainly used in international clinical studies (27.8%), while it was used in national academic studies with less frequency (21.8%). The use of PROMs appeared to increase with professional experience (p<0.05). Among participants, 53.5% stated they had not used PROMs for any purpose. The two most important obstacles to the use of PROMs were lack of time (62.5%) and lack of assisting personnel (35.2%). 25% of participants stated they did not know anything about PROMs. Conclusion: The rate of PROMs use in oncology clinics in Türkiye is 13%, which is much behind the rest of the world, reflecting possible similar patterns in other low- and middle-income regions. This pioneering study underscores the need for strategic initiatives to embed PROs in cancer care, advocating for reforms in health systems.
REFERENCES
  1. Alemayehu D, Cappelleri JC. Conceptual and analytical considerations toward the use of patient-reported outcomes in personalized medicine. Am Health Drug Benefits. 2012;5(5):310-317. [PubMed]  [PMC] 
  2. Lutz AT, Griza A, Machado GM, Loose U, Dahmer A, Herbert JS. Patient reported outcomes in the daily practice in clinical oncology: a systematic review. Crit Rev Oncol Hematol. 2022 May;173:103658. [Crossref]  [PubMed] 
  3. U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006 Oct;4:79. [Crossref]  [PubMed]  [PMC] 
  4. Weldring T, Smith SM. Patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs). Health Serv Insights. 2013 Aug;6:61-68. [Crossref]  [PubMed]  [PMC] 
  5. Mercieca-Bebber R, King MT, Calvert MJ, Stockler MR, Friedlander M. The importance of patient-reported outcomes in clinical trials and strategies for future optimization. Patient Relat Outcome Meas. 2018 Nov;9:353-367. [Crossref]  [PubMed]  [PMC] 
  6. Di Maio M, Basch E, Bryce J, Perrone F. Patient-reported outcomes in the evaluation of toxicity of anticancer treatments. Nat Rev Clin Oncol. 2016;13(5):319-325. [Crossref]  [PubMed] 
  7. Basch E, Iasonos A, McDonough T, et al. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol. 2006;7(11):903-909. [Crossref]  [PubMed] 
  8. Di Maio M, Gallo C, Leighl NB, et al. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials. J Clin Oncol. 2015;33(8):910-915. [Crossref]  [PubMed] 
  9. Warrington L, Absolom K, Conner M, et al. Electronic systems for patients to report and manage side effects of cancer treatment: systematic review. J Med Internet Res. 2019;21(1):e10875. [Crossref]  [PubMed]  [PMC] 
  10. Basch E, Deal AM, Kris MG, Scher HI, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557-565. Erratum in: J Clin Oncol. 2016;34(18):2198. Erratum in: J Clin Oncol. 2019;37(6):528. [Crossref]  [PubMed]  [PMC] 
  11. Barbera L, Sutradhar R, Seow H, et al. Impact of standardized edmonton symptom assessment system use on emergency department visits and hospitalization: results of a population-based retrospective matched cohort analysis. JCO Oncol Pract. 2020;16(9):e958-e965. [Crossref]  [PubMed] 
  12. Basch E, Deal AM, Dueck AC, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;318(2):197-198. [Crossref]  [PubMed]  [PMC] 
  13. Graupner C, Kimman ML, Mul S, et al. Patient outcomes, patient experiences and process indicators associated with the routine use of patient-reported outcome measures (PROMs) in cancer care: a systematic review. Support Care Cancer. 2021;29(2):573-593. [Crossref]  [PubMed]  [PMC] 
  14. Lloyd H, Wheat H, Horrell J, et al. Patient-reported measures for person-centered coordinated care: a comparative domain map and web-based compendium for supporting policy development and implementation. J Med Internet Res. 2018;20(2):e54. [Crossref]  [PubMed]  [PMC] 
  15. Cheung YT, Chan A, Charalambous A, et al. The use of patient-reported outcomes in routine cancer care: preliminary insights from a multinational scoping survey of oncology practitioners. Support Care Cancer. 2022;30(2):1427-1439. [Crossref]  [PubMed]  [PMC] 
  16. Nguyen H, Butow P, Dhillon H, et al. Using patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs) in routine head and neck cancer care: what do health professionals perceive as barriers and facilitators? J Med Imaging Radiat Oncol. 2020;64(5):704-710. [Crossref]  [PubMed] 
  17. Di Maio M, Basch E, Denis F, et al; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline. Ann Oncol. 2022;33(9):878-892. [Crossref]  [PubMed]